Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis

Journal of Nuclear Cardiology

Volumn 26, Issue 3, 2019, Pages 958-970

  Mahmood, Maryam ^a   Kendi, Ayse Tuba ^a   Farid, Saira ^a   Ajmal, Saira ^a   Johnson, Geoffrey B ^a,b   Baddour, Larry M ^a   Chareonthaitawee, Panithaya ^a   Friedman, Paul A ^a   Sohail, M Rizwan ^a  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

CIED; imaging; infection; meta analysis; PET

Indexed keywords

ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CARDIAC PATIENT; DEVICE INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; HUMAN; META ANALYSIS; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ADVERSE DEVICE EFFECT; ARTIFICIAL HEART PACEMAKER; DIAGNOSTIC IMAGING; ENDOCARDITIS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFECTION;

DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS; FLUORODEOXYGLUCOSE F18; HUMANS; PACEMAKER, ARTIFICIAL; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; RADIOPHARMACEUTICALS;

EID: 85029497125     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-017-1063-0     Document Type: Article

References (36)

1. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414-9.
2. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851-9.
3. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-77.
4. Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart. 2012;98(9):724-31.
5. Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, et al. Outcomes in patients with cardiovascular implantable electronic device infection managed with chronic antibiotic suppression. Clin Infect Dis. 2017;64(11):1516-21.
6. Ahmed FZ, James J, Cunnington C, Motwani M, Fullwood C, Hooper J, et al. Early diagnosis of cardiac implantable electronic device generator pocket infection using (1)(8)F-FDG-PET/CT. Eur Heart J Cardiovasc Imaging. 2015;16(5):521-30.
7. Bensimhon L, Lavergne T, Hugonnet F, Mainardi JL, Latremouille C, Maunoury C, et al. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: A preliminary prospective study. Clin Microbiol Infect. 2011;17(6):836-44.
8. Cautela J, Alessandrini S, Cammilleri S, Giorgi R, Richet H, Casalta JP, et al. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: A pilot study. Europace. 2013;15(2):252-7.
9. Graziosi M, Nanni C, Lorenzini M, Diemberger I, Bonfiglioli R, Pasquale F, et al. Role of (1)(8)F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study. Eur J Nucl Med Mol Imaging. 2014;41(8):1617-23.
10. Jimenez-Ballve A, Pérez-Castejón MJ, Delgado-Bolton RC, Sánchez-Enrique C, Vilacosta I, Vivas D, et al. Assessment of the diagnostic accuracy of 18F-FDG PET/CT in prosthetic infective endocarditis and cardiac implantable electronic device infection: Comparison of different interpretation criteria. Eur J Nucl Med Mol Imaging. 2016;43(13):2401-12.
11. Klug DMC, Hossein-Foucher C, Marquie C, Brigadeau F, Lacroix D. Usefulness of PET-CT in the diagnostic strategy in infection of cardiac implantable electronic device. Eur Heart J. 2015;36(suppl 1):1-161.
12. Leccisotti L, Perna F, Lago M, Leo M, Stefanelli A, Calcagni ML, et al. Cardiovascular implantable electronic device infection: Delayed vs standard FDG PET-CT imaging. J Nucl Cardiol. 2014;21(3):622-32.
13. Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: Initial results at an Infective Endocarditis Referral Center. Circulation. 2015;132(12):1113-26.
14. Ploux S, Riviere A, Amraoui S, Whinnett Z, Barandon L, Lafitte S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8(9):1478-81.
15. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59(18):1616-25.
16. Corrigan JG, Whitaker J, Rinaldi A, Barrington SF. Suspected infection of cardiovascular implantable electronic device: Assessment with FDG PET/CT. Eur J Nucl Med Mol Imaging 2014;41(Suppl 2):S151-S705.
17. Remo B, Kim J, Beck H, Klein T, Saliaris A, See V, et al. Fluorine-18 positron emission tomography (18F-FDG PET) to assess cardiovascular implantable electronic devices (CIED) infections: Real life experience from a tertiary extraction center. Heart Rhythm 2014;11(5):Supplement PO01-46.
18. Granados U, Fuster D, Pericas JM, Llopis JL, Ninot S, Qunitana E, et al. Diagnostic accuracy of 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: A cross-sectional study. J Nucl Med. 2016;57(11):1726-32.
19. Tlili G, Amraoui S, Mesguich C, Rivière A, Bordachar P, Hindié E, et al. High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients. J Nucl Cardiol. 2015;22(4):787-98.
20. Le KY, Sohail MR, Friedman PA, Uslan DZ, Hayes DL, Wilson WR, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678-85.
21. Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, et al. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12(1):64-70.
22. Asmar A, Ozcan C, Diederichsen AC, Thomassen A, Gill S. Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis. Eur Heart J Cardiovasc Imaging. 2014;15(9):1013-9.
23. 18F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. Eur J Nucl Med Mol Imaging. 2013;40(8):1190-6.
24. Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P, et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37(6):1189-97.
25. Sohail MR, Eby EL, Ryan MP, Gunnarsson C, Wright LA, Greenspon AJ. Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: Evidence from a large US Payer Database 1-year post implantation. Circ Arrhythm Electrophysiol. 2016;9(8):e003929.
26. Vos FJ, Bleeker-Rovers CP, Kullberg BJ, Adang EM, Oyen WJ. Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia. J Nucl Med. 2011;52(11):1673-8.
27. ACR-SPR practice parameter for performing FDG-PET /CT in oncology. 2016; https://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/FDG_PET_CT.pdf.
28. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: Version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328-54.
29. Tang R, Wang JT, Wang L, Le K, Huang Y, Hickey AJ, et al. Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: A systematic review and meta-analysis. Clin Nucl Med. 2016;41(7):e327-39.
30. Lu Y, Grant C, Xie K, Sweiss NJ. Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. Clin Nucl Med. 2017;42(2):88-94.
31. Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017;24(1):86-99.
32. Buther F, Vehren T, Schäfers KP, Schäfers M. Impact of data-driven respiratory gating in clinical PET. Radiology. 2016;281(1):229-38.
33. Rubeaux M, Moris MK, Alessio A, Slomka PJ. Enhancing cardiac PET by motion correction techniques. Curr Cardiol Rep. 2017;19(2):14.
34. Ahmed FZ, James J, Tout D, Arumugam P, Mamas M, Zaidi AM. Metal artefact reduction algorithms prevent false positive results when assessing patients for cardiac implantable electronic device infection. J Nucl Cardiol. 2015;22(1):219-20.
35. DiFilippo FP, Brunken RC. Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT? J Nucl Med. 2005;46(3):436-43.
36. Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: A systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10(4):e005772.